Celecoxib, a nonsteroidal anti-inflammatory drug (NSAID) and a selective cyclooxygenase-2 (COX-2) inhibitor, was shown to exert beneficial actions in cancer-induced cachexia patients [9]. This evidence concerns the gene PTGS2 and cancer.